National Institute of Mental Health and Neurosciences and partners met in Bengaluru to unveil a draft national framework for digital mental‑health tools. [1]

The meeting comes as India grapples with a mental‑health burden that touches roughly one in seven citizens, or about 14 percent of the population, while many states report treatment gaps as high as 90 percent.[3] At the same time, hundreds of mental‑health apps are available to consumers, most with limited information about efficacy, data privacy, or clinical validation.[2] Officials said a coordinated regulatory approach is essential to protect users and to help them make informed choices.

The proposed framework outlines three pillars. First, a governance board would set standards for clinical evidence, data security, and user consent. Second, an official app‑verification portal would list only those applications that meet the criteria, creating a trusted repository for clinicians and the public. Third, the plan calls for a nationwide digital‑literacy campaign to educate users about how to evaluate mental‑health technologies and understand their rights.[1]

Stakeholders said the repository would be managed by a joint task force of NIMHANS, the Ministry of Health and leading tech firms, ensuring that updates to standards keep pace with rapid innovation.[2] The framework also recommends periodic audits, penalties for non‑compliant apps, and incentives for developers who incorporate evidence‑based interventions.

Pilot testing is slated for the next six months in selected states, after which the board will refine the guidelines before seeking parliamentary approval. If adopted, the system could streamline access to safe digital therapies and reduce the current treatment gap, especially in underserved rural areas.[3]

Hundreds of mental‑health apps circulate with little oversight.

If the framework moves from draft to law, India could become a model for regulating digital mental‑health services, balancing innovation with consumer protection and potentially narrowing the massive treatment gap that leaves millions without care.